Planning Pregnancy
Planning Pregnancy for a person with a chronic illness who is on long-term medication.
In this article, we will use Biotandem to explore what steps should be taken, when a person with a chronic illness who is on long term medications wants to have a child.
If this individual is already one of your biotypes in Biotandem, their biotype would include details, such as twenty eight years old female, diagnosed with Crohn's disease and asymptomatic on adalimumab and azathioprine.
The details of the Crohn's disease is here.
All we need to do is add the wish to conceive feature either by from the search bar or from the reproductive status section.
That's it.Now, let's go to the biobook tab to review personalized knowledge set for this biotype.
By selecting wish to conceive feature from the index, we can examine all necessary pre pregnancy steps for this biotype.
We also select Crohn's disease from the index on the left side.
We can explore all the necessary considerations for this condition in both gastrointestinal and female reproductive systems.
For example, if you select the gastrointestinal section and select the risk subsection, you we can see how pregnancy might affect Crohn's disease.
And on the medical treatment subsection, we see the insights into treatment adjustments.
In the counseling section, it offers guidance on patient education and preparation.
Additionally, by selecting adalimumab, we can review what needs to be considered regarding this medication before pregnancy. If you did this with removing Crohn's disease, you will see all the information, specifically Crohn's treatment with adalimumab.
Under the reproductive section, if you select risk subsection, you see the information of adalimumab on reproductive risks and compare recommendations from different medical organizations.
The same steps can be followed for azathioprine also.
The complete review of medication related considerations like risks for azathioprine and compare again from different organizations for this biotype.
Thank you.